Overview

A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria

Status:
RECRUITING

Trial end date:
2026-07-31

Target enrollment:

Participant gender:

Summary

A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants with Chronic Kidney Disease and High Proteinuria (ZODIAC)

Phase:

PHASE2

Details

Lead Sponsor:

AstraZeneca

Treatments:

dapagliflozin
ZD4054